In secondary end points, PASI 100 achievement rates were 40.6% with ixekizumab plus tirzepatide vs 29.0% with ixekizumab alone, and rates of 10% or greater weight loss were 69.2% with ixekizumab plus tirzepatide vs 9.1% with ixekizumab alone
Regular follow-ups with healthcare providers are essential to track progress, adjust treatment plans, and address any potential side effects, such as gastrointestinal discomfort, ensuring the most effective and comfortable weight loss journey
By addressing common mistakessuch as misunderstanding concentration levels and incorrect unit measurementswe can enhance treatment outcomes
Edelman, Im confused about the SGLT2s and GLP-1 RAs
Compounded Injectable Tirzepatide A once-weekly injection
Step 7: Lift the pen straight away from your skin